Drug regulator okays psoriasis injection for limited use in treating COVID-19 patients

Considering the unmet medical needs to treat COVID-19, Drugs Controller General of India Dr V G Somani approved monoclonal antibody injection Itolizumab for restricted emergency use for the treatment of 'cytokine' release syndrome in moderate to severe acute respiratory distress syndrome patients due to COVID-19.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gOVNes
via IFTTT